Detail akcie DAIICHI SANKYO online

Business Summary: Daiichi Sankyo Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.
Financial Summary: BRIEF: For the fiscal year ended 31 March 2025, Daiichi Sankyo Co Ltd revenues increased 18% to Y1.886T. Net income applicable to common stockholders excluding extraordinary items increased 46% to Y295.76B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from NOP Equity Loss increase from Y184M to Y1.46B (income), Other income increase of 5% to Y28.74B (income).